SA

Subramanyam Achutha

Active Director Director DIN 09179004
DIN 09179004 First appointment May 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value •••• Premium profile

About Subramanyam Achutha

Data last updated:

Subramanyam Achutha is a Director at Vinkind Pharmaceuticals Private Limited (since 2021). The company operates in Trading. Vinkind Pharmaceuticals Private Limited reported revenue of ₹39.1 Lakh (FY 2024).

DIN 09179004
Primary Designation Director
Industry Trading
First Appointment 19 May 2021
Oldest Company Age 5 yrs
Largest company Vinkind Pharmaceuticals Private Limited · ₹39.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 May 20212021₹39.1 Lakh (FY 2024)Active

Board colleagues of Subramanyam Achutha

NameDINCompanyDesignation
Sirisha Alampalli09179003Vinkind Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Vinkind Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Subramanyam Achutha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subramanyam Achutha

Subramanyam Achutha currently holds 1 directorship: Vinkind Pharmaceuticals Private Limited (Director, since 19 May 2021, revenue ₹39.1 Lakh (FY 2024)).

Subramanyam Achutha was first appointed on 19 May 2021 as Director at Vinkind Pharmaceuticals Private Limited.

The current boards of Subramanyam Achutha's companies include Sirisha Alampalli (Vinkind Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available